Nu‑Tek At ESACT 2026: Animal‑Origin‑Free Peptones And Variability Reduction Program Data

Raw material variability remains a critical challenge for teams developing and manufacturing cell‑based bioprocesses. Inconsistent performance can disrupt scale‑up, delay technology transfer, and increase operational risk and cost. At ESACT 2026 in Salzburg, attendees can review real‑world data demonstrating how a structured, collaborative approach to variability reduction supports more robust and predictable culture media performance.

View highlights of how focusing on critical material attributes, tighter specifications, and enhanced data analysis can help identify and control key sources of variation. By integrating animal‑origin‑free media strategies with process insights, teams can strengthen consistency across development and commercial manufacturing while improving supply chain resilience.

Designed for bioprocess, MSAT, and procurement leaders, the session emphasizes practical lessons learned, measurable outcomes, and opportunities to improve productivity without compromising regulatory or operational goals. The discussion centers on actionable insights to support long‑term performance, scalability, and cost control in modern bioprocessing environments.